Results 131 to 140 of about 4,356 (162)

Machine learning enhanced acute heart failure phenotype prediction using natural language processing and random forest. [PDF]

Front Artif Intell
Chang PH, Liao FC, Wu YC, Sun FJ, Liu YY, Yeh HI, Hung CL, Wu KP.   +7 more
europepmc   +1 more source

[Anaemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Rivera RF, Sciarrone Alibrandi MT.
europepmc   +1 more source

Clinical outcomes of SGLT2 inhibitor use in Thai patients with heart failure: a five-year retrospective cohort study. [PDF]

Int J Cardiol Heart Vasc
Chanchanayothin T, Klomwong C, Saisri T, Panudom S, Chaiyamahapurk S, Theerasuwipakorn N, Siranart N, Pajareya P, Songsirisuk N, Pravarnpat C, Pipatputthapong A, Jittham P, Kosum P.   +12 more
europepmc   +1 more source

Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction. [PDF]

Nat Med
Vaduganathan M, Claggett BL, Chatur S, Desai AS, Jhund PS, Vardeny O, Merkely B, Martinez F, Comin-Colet J, Kerr Saraiva JF, Shah SJ, Lam CSP, Zannad F, Docherty KF, McMurray JJV, Solomon SD.   +15 more
europepmc   +1 more source

Anemia in Heart Failure: Diagnostic Insights and Management Patterns Across Ejection Fraction Phenotypes. [PDF]

Diagnostics (Basel)
Țica O, Țica O.
europepmc   +1 more source

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Yang M, Henderson AD, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Rouleau JL, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Rizkala A, Lewis EF, Jhund PS, Solomon SD, McMurray JJV.   +18 more
europepmc   +1 more source

Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study [PDF]

Balkan Med J
Ke J, Qiu X, Wang M, Zeng H, Wang C, Zhang J, Zhu H, Gu J.   +7 more
europepmc   +1 more source

Very long-term LVEF dynamics and prognosis in HFrEF and HFmrEF

, 2017
de Antonio, M, Lupon, J, Lopez-Ayerbe, J, Moliner, P, Domingo, M, Ferrer, E, Zamora, E, Vallejo, N, Gual, F, Teis, A, Junca, G, Troya, MI, Rodriguez, M, Gonzalez, B, Bayes-Genis, A   +14 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF): Lichtstreifen am Horizont?

Aktuelle Kardiologie, 2021
ZusammenfassungEine evidenzbasierte medikamentöse Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF) ist bislang, im Gegensatz zur systolischen Herzinsuffizienz (HFrEF), nicht etabliert. Die ESC-Leitlinien 2016 empfehlen als einzige Substanzklasse Diuretika zur Symptomverbesserung.
openaire   +1 more source

Prognostic impact of lung ultrasound detected B-Line on hospitalized ischemic HFmrEF patients

European Heart Journal, 2023
Abstract Background The prognostic impact of lung ultrasound derived B-Line (LU-BL) in heart failure patients with mildly reduced left ventricular ejection fraction (HFmrEF) remains elusive. We evaluated the correlation between LU-BL and prognosis in HFmrEF patients.
Y L Zhu, H Zhang, Y Y Zhou, F Q Chen, N Li, X Peng, M X Wu, H B Huang, L L Zhang, M Liao, S H A Xiao, Y L Chen, S H Chen, Z C Liu, J P Zeng   +14 more
openaire   +1 more source